Home /Research /A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinoma
OTHER

A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinoma

Fumihiko Urabe, Keigo Sakanaka, Yuma Goto, Katsuki Muramoto, Soshi Kadena, Hajime Onuma, Kosuke Iwatani, Yu Imai, Kojiro Tashiro, Takahiro Kimura, Tatsuya Shimomura

Year
2025
Citations
1

Keywords

PembrolizumabOncologyMedicineMetastatic Urothelial CarcinomaUrothelial carcinomaInternal medicineCancer researchCancerImmunotherapyBladder cancer

Related papers

Browse all OTHER papers